Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981

British Journal of Dermatology

Volumn 142, Issue 4, 2000, Pages 669-679

  Neckermann, G ^a   Bavandi, A ^a   Meingassner, J G ^a  

^a NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

Anti inflammatory activity; Ascomycin macrolactam derivative; Atopic dermatitis like eczema; Hypomagnesaemic rats; SDZ ASM 981

Indexed keywords

PIMECROLIMUS;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; ATOPY; CONTROLLED STUDY; DERMATITIS; HISTOPATHOLOGY; HYPOMAGNESEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; RAT; RAT STRAIN; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; MAGNESIUM DEFICIENCY; MALE; RATS; RATS, NUDE; TACROLIMUS;

EID: 0034087633     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03411.x     Document Type: Article

References (51)

1. 1 Saurat JH, Chavaz P, Barbier A, Faucher F. Dermatosis in hairless rats fed a low magnesium diet. In: Models in Dermatology (Maibach HI, Lowe NJ. eds), Vol. 1. Basel: Karger, 1985; 202-9.
2. 2 Claverie-Benureau S, Lebel B, Gaudin-Harding F. Magnesium deficiency allergy-like crisis in hairless rats. A suggested model for inflammation studies. J Physiol 1980; 76: 173-5.
3. 3 Saurat JH, Chavaz P, Ponvert C, Gallopin L. Skin inflammation induced by hypomagnesaemia in the rat. Br J Dermatol 1983; 109 (Suppl. 25): 106-10.
4. 4 Ponvert C, Galoppin L, Saurat JH. The dermatosis of hairless rats fed a hypomagnesaemic diet. I. Course, clinical features and inhibition by drugs. Clin Exp Dermatol 1983; 8: 539-47.
5. 5 Barbier A, Planchenault C, Vernhet C, Breliere JC. Dermatosis in magnesium-deficient hairless rats: effects of steroidal and non-steroidal anti-inflammatory drugs. Agents Actions 1985; 17: 352-4.
6. 6 Bavandi A, Meingassner JG, Becker S. Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK 506. Exp Dermatol 1992; 1: 199-205.
7. 7 Classen CU, Abele C, Schimatscheck HF et al. Erythema formation in magnesium-deficient albino rats. A non-invasive model for the screening of anti-inflammatory agents and oral mineral supplements. Arzneim-Forsch/Drug Res 1993; 43: 672-5.
8. 8 Bois P, Byrne EH, Bélanger LF. Effect of magnesium deficiency on the regeneration of mast cells after treatment with 48/80 in rats. Can J Biochem Physiol 1960; 38: 585-9.
9. 9 Bois P, Gascon A, Beaulnes A. Histamine-liberating effect of magnesium deficiency in the rat. Nature 1963; 197: 501-2.
10. 10 Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr 1980; 110: 851-8.
11. 11 Bélanger LF, Van Erkel GA, Jakerow A. Behaviour of the dermal mast cells in magnesium-deficient rats. Science 1957; 126: 29-30.
12. 12 Itokowa Y, Tanaka C, Kimura M. Effect of thiamine on serotonin levels in Mg-deficient animals. Metabolism 1972; 21: 375-9.
13. 13 Hungerford GF. Role of histamine in producing the eosinophilia of magnesium deficiency. Proc Soc Exp Biol Med 1964; 115: 182-5.
14. 14 Rock E, Astier C, Lab C et al. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnesium Res 1995; 8: 237-42.
15. 15 Hanada K, Hashimoto I. Superoxide anion in polymorphonuclear leukocytes of hairless rats suffering from magnesium deficiency dermatitis. J Dermatol 1989; 16: 270-5.
16. 16 Mease AD. Carcinogenic potential of magnesium deficiency. Lancet 1974; ii: 590-1.
17. 17 Alcock NW, Shils ME, Liebermann LH, Erlandson RA. Thymic changes in the Mg-depleted rat. Cancer Res 1973; 33: 2196-204.
18. 18 Prouvost-Danon A, Larvor P, Rayssiguier Y et al. Taux sérique d'anticorps réaginiques (IgE) chez la souris en carence magnésique. Rev Fr Allergol 1975; 15: 147-50.
19. 19 Alcock NW, Shils ME. Serum immunoglobulin G in the magnesium depleted rat. Proc Soc Exp Biol Med 1974; 145: 855-8.
20. 20 McCoy JH, Keney MA. Depressed immune response in the magnesium-deficient rat. J Nutr 1975; 105: 791-7.
21. 21 Elin RJ. The effect of magnesium deficiency in mice on serum immunoglobulin concentrations and antibody plaque-forming cells. Proc Soc Exp Biol Med 1975; 148: 620-4.
22. 22 Weglicki WB, Philipps TM, Freedman AM et al. Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992; 110: 169-73.
23. 23 Rayssiguier Y, Mazur A, Gueux E, Rock E. Magnesium deficiency affects lipid metabolism and atherosclerosis processes by mechanisms involving inflammation and oxidative stress. Magnesium Res 1994; 7: 46-7.
24. 24 Holden CA, Parish WE. Atopic dermatitis. In: Textbook of Dermatology (Champion RH, Burton JL, Burn DA, Breathnach SM, eds), 6th edn. Oxford: Blackwell Science, 1998; 681-708.
25. 25 Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92: 44-7.
26. 26 Van Leent EJM, Gräber M, Thurston M et al. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998; 134: 805-9.
27. 27 Queille-Roussel C, Graeber M, Wagenaar A et al. Topical treatment with the anti-inflammatory macrolactam SDZ ASM 981 inhibits established nickel contact dermatitis. Australas J Dermatol 1997; 38 (Suppl 2): Abstr. 3039.
28. 28 Grassberger M, Baumruker T, Enz A et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 1999; 141: 264-73.
29. 29 Meingassner JG, Grassberger M, Fahrngruber H et al. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 1997; 137: 568-76.
30. 30 Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin and FK 506. Immunol Today 1992; 13: 136-42.
31. 31 Andersson J, Nagy S, Groth CG, Andersson U. Effects of FK 506 and cyclosporine A on cytokinc production studied in vitro at a single cell level. Immunology 1992; 75: 136-42.
32. 32 Weglicki WB, Dickens BF, Wagner TL et al. Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnesium Res 1996; 9: 3-11.
33. 33 Hultsch T, Mueller KD, Meingassner JG et al. Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. Arch Dermatol Res 1998; 290: 501-7.
34. 34 de Paulis A, Cirillo R, Ciccarelli A et al. Characterization of the anti-inflammatory effect of FK 506 on human mast cells. J Immunol 1991; 147: 4278-85.
35. 35 Stellato C, de Paulis A, Ciccarelli A et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98: 800-4.
36. 36 Ponvert C, Galoppin L, Burtin C et al. Noninvolvement of histamine and prostaglandins in the dermatosis of magnesium-deficient hairless rats. Pharmacology 1984; 28: 235-40.
37. 37 Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996; 26: 15-19.
38. 38 Levi-Schaffer F, Weg VB. Mast cells, eosinophils and fibrosis. Clin Exp Allergy 1997; 27 (Suppl. 1): 64-70.
39. 39 Loveren HV, Redegeld F, Matsuda H et al. Mast cells. In: Skin Immune System (SIS) (Bos JD. ed.), 2nd edn. Boca Raton, FL: CRC Press, 1997; 159-84.
40. 40 Mora de F, Williams CMM, Frenette PS et al. P- and E-selectins are required for the leukocyte recruitment, but not the tissue swelling, associated with IgE-and mast cell-dependent inflammation in mouse skin. Lab Invest 1998; 78: 497-505.
41. 41 Walls AF. The roles of neutral proteases in asthma and rhinitis. In: Asthma and Rhinitis (Busse WW, Holgate ST, eds). Boston: Blackwell Science, 1995; 801-9.
42. 42 He S, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 1997; 159: 6216-25.
43. 43 Hägermark Ö. Itch mediators. Semin Dermatol 1995; 14: 271-6.
44. 44 Greaves MW. Anti-itch treatments: do they work? Skin Pharmacol 1997; 10: 225-9.
45. 45 Wahlgren CF, Scheynius A, Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol (Stockh) 1990; 70: 323-9.
46. 46 Mak IT, Komarov AM, Wagner TL et al. Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss. Am J Physiol 1996; 271 (Cell Physiol 40): C385-90.
47. 47 Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
48. 4 receptor antagonist against hypomagnesic diet-induced dermatitis in hairless rats. J Dermatol 1992; 19: 456-60.
49. 49 Weglicki WB, Stafford RE, Freedman AM et al. Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model. Am J Physiol 1993; 264 (Cell Physiol 33): C723-6.
50. 50 Freedman AM, Atrakchi AH, Cassidy MM, Weglicki WB. Magnesium deficiency-induced cardiomyopathy: protection by vitamin E. Biochem Biophys Res Commun 1990; 170: 1102-6.
51. 51 Conde M, Andrade J, Bedoya FJ et al. Inhibitory effect of cyclosporin A and FK 506 on nitric oxide production by cultured macrophages. Immunology 1995; 84: 476-81.